Big Data Analytics for Prostate Radiotherapy
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Radiation therapy is a first-line treatment option for localized prostate cancer and radiation-induced normal tissue damage are often the main limiting factor for modern radiotherapy regimens. Conversely, under-dosing of target volumes in an attempt to spare adjacent healthy tissues limits the likelihood of achieving local, long-term control. Thus, the ability to generate personalized data-driven risk profiles for radiotherapy outcomes would provide valuable prognostic information to help guide both clinicians and patients alike. Big data applied to radiation oncology promises to deliver better understanding of outcomes by harvesting and integrating heterogeneous data types, including patient-specific clinical parameters, treatment-related dose-volume metrics, and biological risk factors. When taken together, such variables make up the basis for a multi-dimensional space (the "RadoncSpace") in which the presented modeling techniques search in order to identify significant predictors. Herein, we review outcome modeling and big data-mining techniques for both tumor control and radiotherapy-induced normal tissue effects. We apply many of the presented modeling approaches onto a cohort of hypofractionated prostate cancer patients taking into account different data types and a large heterogeneous mix of physical and biological parameters. Cross-validation techniques are also reviewed for the refinement of the proposed framework architecture and checking individual model performance. We conclude by considering advanced modeling techniques that borrow concepts from big data analytics, such as machine learning and artificial intelligence, before discussing the potential future impact of systems radiobiology approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systems biology: a brief overview
Kitano, H. (2002) · Science · doi:10.1126/science.1069492 · Cited by 4,265
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
Use of Normal Tissue Complication Probability Models in the Clinic
Marks, L. B., Yorke, E. D., Jackson, A., Ten Haken, R. K., Constine, L. S., Eisbruch, A., Bentzen, S. M., Nam, J., & Deasy, J. O. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.07.1754 · Cited by 1,826 · cited 4×
“In recent years, however, it has been demonstrated that dose–volume metrics, while straightforward to obtain and contributing significantly to the analysis of radiotherapy outcomes, are not the only determining factors of success in predicting radiotherapy outcomes (11, 12).”
BackgroundMethodInfluentialModel selection for ecologists: the worldviews of AIC and BIC
Aho, K., Derryberry, D., & Peterson, T. (2014) · Ecology · doi:10.1890/13-1452.1 · Cited by 1,165 · cited 1×
“Therefore, the two methods discussed herein only indicate relative measures of fit and do not give any information on the quality of any model in an absolute sense (143).”
MethodA MicroRNA Signature of Hypoxia
Kulshreshtha, R., Ferracin, M., Wojcik, S. E., Garzon, R., Alder, H., Agosto-Perez, F. J., Davuluri, R., Liu, C.-G., Croce, C. M., Negrini, M., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01395-06 · Cited by 1,055 · cited 1×
“In the case of radiation oncology, high-throughput data have yielded several multi-gene signatures for hypoxia (79–81).”
BackgroundLung Nodule Classification Using Deep Features in CT Images
Kumar, D., Wong, A., & Clausi, D. A. (2015) · 2015 12th Conference on Computer and Robot Vision · doi:10.1109/crv.2015.25 · Cited by 398
Integrative data analysis of multi-platform cancer data with a multimodal deep learning approach
Liang, M., Li, Z., Chen, T., & Zeng, J. (2015) · IEEE/ACM Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2014.2377729 · Cited by 231
Cited by
Current Applications and Future Impact of Machine Learning in Radiology
Choy, G., Khalilzadeh, O., Michalski, M., Do, S., Samir, A. E., Pianykh, O. S., Geis, J. R., Pandharipande, P. V., Brink, J. A., & Dreyer, K. J. (2018) · Radiology · doi:10.1148/radiol.2018171820 · Cited by 800
“More work on automated radiation dose estimation has been done in the field of radiation oncology, which has the potential for similar applications in diagnostic radiology (69,70).”
Survey on deep learning for radiotherapy
Meyer, P., Noblet, V., Mazzara, C., & Lallement, A. (2018) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2018.05.018 · Cited by 302
Clinical text classification research trends: Systematic literature review and open issues
Mujtaba, G., Shuib, L., Idris, N., Hoo, W. L., Raj, R. G., Khowaja, K., Shaikh, K., & Nweke, H. F. (2019) · Expert Systems with Applications · doi:10.1016/j.eswa.2018.09.034 · Cited by 123
Radiomics in radiooncology – challenging the medical physicist
Peeken, J. C., Bernhofer, M., Wiestler, B., Goldberg, T., Cremers, D., Rost, B., Wilkens, J. J., Combs, S. E., & Nüsslin, F. (2018) · Physica Medica · doi:10.1016/j.ejmp.2018.03.012 · Cited by 98
Kang, J., Thompson, R. F., Aneja, S., Lehman, C., Trister, A., Zou, J., Obcemea, C., & El Naqa, I. (2021) · Practical Radiation Oncology · doi:10.1016/j.prro.2020.06.001 · Cited by 30
Metadata
- Authors
- Coates, J., Souhami, L., & El Naqa, I.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2016-06-14
- Volume
- 6
- Pages
- 149-149
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2423965850
- Cited by
- 36
- References
- 7
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.